This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A randomised phase 2 study of paclitaxel with or w...
Clinical trial

A randomised phase 2 study of paclitaxel with or without GSK1120212 in advanced wt BRAF melanoma

Read time: 1 mins
Last updated:28th Nov 2011
Phase 1 - To establish the maximum tolerated dose of GSK1120212 in combination with paclitaxel in the treatment of patients with advanced melanoma. Phase 2 - To compare the efficacy of GSK1120212 in combination with paclitaxel, compared with paclitaxel alone in the treatment of patients with advanced or metastatic melanoma.
Category Value
Study start date 2011-11-28

View full details